# DataMeds AI, Inc. (WGRX) — capital_raise/atm_program [pending]
Source: SEC API (secapi.ai) · situation sit_5a3ec64789723519779b · retrieved 2026-08-12T07:24:08.363Z

## Overview
DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) operates a pharmaceutical distribution and healthcare technology platform, with existing blockchain-enabled distribution technology and a PharmacyChain license.

DataMeds AI, Inc. entered into an Amended and Restated Letter of Intent on July 29, 2026, with EOS Technology Holdings, Inc., Scilex Holding Company, Datavault AI Inc., and HealthBridge Advisors, LLC to acquire or exclusively license Quality of Life Peace of Mind (QLPM)-related intellectual property assets from EOS and Scilex, expand its existing PharmacyChain license with Datavault to exclusively include Datavault AI Health, and acquire a controlling interest in Tollo Health, LLC through an exchange of membership interests. The consideration consists solely of common stock ("Acquisition Stock"), with no preferred stock, convertible securities, or contingent conversion features. Upon closing, EOS, Scilex, Datavault, and HBA are expected to own in aggregate approximately 84.6% of the Company's common stock (EOS 19.9%, Scilex 19.9%, Datavault 19.9%, HBA 24.9%), with Fortitude expected to own approximately 5% and existing public stockholders approximately 10.4%, on a fully diluted basis. The transaction remains subject to due diligence, negotiation and execution of definitive agreements, receipt of a fairness opinion, board and stockholder approvals, Nasdaq compliance, and other customary conditions.

## Terms
- Counterparty: EOS Technology Holdings, Inc.; Scilex Holding Company; Datavault AI Inc.; HealthBridge Advisors, LLC · Consideration: stock · Stake: 84.6%

## Key dates
- Announced 2026-08-04 · Expiry 2026-09-30

## Timeline
- 2026-08-04 · 8-K (0001493152-26-036005): 8-K - DataMeds AI, Inc. — *DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) operates a pharmaceutical distribution and healthcare technology platform, with existing blockchain-enabled distribution technology and a PharmacyChain license.* DataMeds AI, Inc. entered into an Amended and Restated Letter of Intent on July 29, 2026, with EOS Technology Holdings, Inc., Scilex Holding Company, Datavault AI Inc., and HealthBridge Advisors, LLC to acquire or exclusively license Quality of Life Peace of Mind (QLPM)-related intellectual property assets from EOS and Scilex, expand its existing PharmacyChain license with Datavault to exclusively include Datavault AI Health, and acquire a controlling interest in Tollo Health, LLC through an exchange of membership interests. The consideration consists solely of common stock ("Acquisition Stock"), with no preferred stock, convertible securities, or contingent conversion features. Upon closing, EOS, Scilex, Datavault, and HBA are expected to own in aggregate approximately 84.6% of the Company's common stock (EOS 19.9%, Scilex 19.9%, Datavault 19.9%, HBA 24.9%), with Fortitude expected to own approximately 5% and existing public stockholders approximately 10.4%, on a fully diluted basis. The transaction remains subject to due diligence, negotiation and execution of definitive agreements, receipt of a fairness opinion, board and stockholder approvals, Nasdaq compliance, and other customary conditions.
  https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-036005.txt

## Citations
- 0001493152-26-036005 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226036005